Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Reticulocyte hemoglobin content for the diagnosis of iron deficiency in young children with acute infection

급성 감염성 질환을 가진 영유아에서 철결핍 진단 지표로서의 망상적혈구혈색소량

  • Kim, Jon Soo (Department of Pediatrics, College of Medicine, Eulji University) ;
  • Choi, Jun Seok (Department of Pediatrics, College of Medicine, Eulji University) ;
  • Choi, Doo Young (Department of Pediatrics, College of Medicine, Eulji University) ;
  • You, Chur Woo (Department of Pediatrics, College of Medicine, Eulji University)
  • 김존수 (을지대학교 의과대학 소아과학교실) ;
  • 최준석 (을지대학교 의과대학 소아과학교실) ;
  • 최두영 (을지대학교 의과대학 소아과학교실) ;
  • 유철우 (을지대학교 의과대학 소아과학교실)
  • Received : 2008.03.02
  • Accepted : 2008.07.11
  • Published : 2008.08.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Early identification of iron deficiency in young children is essential to prevent damaging long-term consequences. It is often difficult for the pediatrician to know which indices should be used when diagnosing these conditions especially in hospitalized young children. This study investigated the clinical significances of reticulocyte hemoglobin content in young children with acute infection. Methods : We studied 69 young children aged from 6 to 24 months admitted with acute infection in a single center. Venous blood was drawn to determine hemoglobin (Hb), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), hemoglobin content (CH), reticulocyte hemoglobin content (CHr), and red blood cell distribution width (RDW) using ADVIA 120 (Bayer Diagnostics, NY, USA). For evaluating iron status, iron, total iron binding capacity, ferritin and transferrin saturation (Tfsat) were determined. Iron deficiency was defined as Tfsat less than 20%, and iron deficiency anemia as Tfsat less than 20% and Hb level less than 11 g/dL. Results : In all, 47 were iron deficient; 17 of these had iron deficiency anemia. CHr was the only significant predictor of iron deficiency (likelihood ratio test=71.25; odds ratio=0.67; P<0.05). Plasma ferritin level had no predictive value (P=0.519). Subjects with CHr less than 27.4 pg had lower Hb level, MCH, CH, Tfsat, and iron levels than those with CHr 27.4 pg or more (P<0.05 for all). Conclusion : CHr level was a sensitive screening tool and the strongest predictor of iron deficiency in hospitalized infants with acute infection; it was cost saving and avoiding additional sampling. However its reference range should be established.

목 적 : 영유아기에 발생하는 철 결핍성 빈혈은 성장, 발달에 심각한 영향을 미칠 수 있으므로 철 결핍을 조기 진단하는 것은 매우 중요하다. 고식적으로 사용되고 있는 혈청 ferritin이나 iron 대신 염증이나 만성질환 등에 영향을 받지 않고 철 결핍 상태를 진단하는데 비용이나 혈액채취량의 부담을 줄일 수 있는 장점이 있는 망상적혈구혈색소량을 다른 철 결핍 지표들과 함께 비교하였다. 방 법 : 2006년 6월부터 2007년 1월까지 을지대학병원 소아과에 급성 감염성 질환으로 입원한 생후 6개월에서 24개월 영유아를 대상으로 하였다. 정맥혈을 채혈하여 ADVIA 120 (Bayer Diagnostics, NY, USA)을 이용하여 Hb, MCV, MCH, CH, CHr, RDW를 검사하였고, 철 상태를 평가하기 위하여 iron, iron binding capacity, ferritin을 측정하였다. 혈색소 11 g/dL, Tfsat 20%를 기준으로 철 결핍성 빈혈군, 철 결핍군, 철 결핍이 없는 군을 나누었다. 결 과 : 총 69명의 영유아 중 철 결핍이 있는 환아가 47명, 이중 17명이 철 결핍성 빈혈군에 해당되었으며 철 결핍이 없는 군이 22명이었다. 빈혈을 포함한 철 결핍이 있는 집단과 철 결핍이 없는 군과는 MCH (P<0.01), CH (P<0.01), RDW (P<0.05) 및 CHr (P<0.01)이 유의하게 차이가 있었지만, ferritin은 두 집단 간에 차이가 없었다(P=0.109). CHr은 철결핍에 유의한 예측변수로 나타났다(LRT=71.25; odds ratio=0.67 [95% 신뢰구간, 0.47-0.97]; P<0.05). 철 결핍군을 빈혈이 있는 집단과 빈혈이 없는 집단과 비교하였을 때 MCV, MCH, CH, RDW가 유의한 차이를 보였다(모두 P<0.05). 또한 CHr, iron, TIBC, ferritin은 두 군간에 차이가 없었다(P>0.05). CHr의 cutoff 27.4 pg을 기준으로 전체 집단을 구분하여 비교하였을 경우에는 Hb, MCH, CH, Tfsat, iron (모두 P<0.05) 모두 통계적으로 유의한 차이를 보였으나 MCV (P=0.188), RDW (P=0.138), ferritin (P=0.730), TIBC (P=0.700)는 차이를 보이지 않았다. 결 론 : CHr은 일부 기종에 국한되어 제공되는 사항이고 적절한 참고치의 설정이 필요하지만, 6개월에서 24개월령의 유소아에서 철 결핍 상태를 진단하는데 급성염증반응에 영향을 받지 않고, 비용이나 혈액채취량의 부담을 줄일 수 있는 장점이 있어 새로운 지표로 이용이 가능하리라 생각된다.

Keywords

References

  1. DeMaeyer E, Adiels-Teyman M. The prevalence of anemia in the world. World Health Stat Q 1985;38:302-16
  2. Reeves JD. Iron supplementation in infancy. Pediatr Rev 1986;8:177-84 https://doi.org/10.1542/pir.8-6-177
  3. Kim HS, Rhee KJ, Kim TW. Incidence of iron deficiency anemia and changes in serum ferritin level in various childhood diseases. J Korean Pediatr Soc 1982;25:800-6
  4. Hong CY. Iron deficiency anemia. Korean J Med 1973;16: 295-301
  5. Pollitt E. The developmental and probabilistic nature of the functional consequences of iron-deficiency anemia in children. J Nutr 2001;131:S669-75
  6. Pollit E, Leibel RL. Iron deficiency and behavior. J Pediatr 1976;88:372-81 https://doi.org/10.1016/S0022-3476(76)80250-8
  7. Walter T, Kovalskys J. Stekel A. Effect of mild iron deficiency on infant mental development scores. J Pediatr 1983;102:519-22 https://doi.org/10.1016/S0022-3476(83)80177-2
  8. Leibel RL, Pollite E, Kim I, Viteri F. Studies regarding the impact of micronutrient status on behavior in man: Iron deficiency as a model. Am J Clin Nutr 1982;35:1211-21 https://doi.org/10.1093/ajcn/35.5.1211
  9. Dallman PR, Siimes MA, Manies EC, Brain Iron. Persistent deficiency following short term iron deprivation in young rat. Br J Haematol 1975;31:209-15 https://doi.org/10.1111/j.1365-2141.1975.tb00851.x
  10. Lozoff B, Brittenham GM, Wolf AW, McClish DK, Kuhnert PM, Jimenez E, et al.: Iron deficiency anemia and iron therapy effects on infant developmental test performance. Pediatrics 1987;79:981-95
  11. Kwik-Uribe CL, Golubt MS, Keen CL. Behavioral consequence of marginal iron deficiency during development in a murine model. Neurotoxicol Teratol 1999;21:661-72 https://doi.org/10.1016/S0892-0362(99)00041-0
  12. Iron deficiency anemia: assessment, prevention and control. A guide for programme managers. Geneva, World Health Organization, 2001;1-114. Abaviable at http//whqlibdoc.who. int/hq/2001!WHO_NHD_01.3.pdf
  13. Saarinen UM, Siimes MA. Serum ferritin in assessment of iron nutrition in healthy infants. Acta Paediatr Scand 1978; 67:745-51 https://doi.org/10.1111/j.1651-2227.1978.tb16254.x
  14. Yip R, Schwartz S, Deinard A. Screening for iron deficiency with erythrocyte protoporphyrin test. Pediatrics 1983;72:214-9
  15. Kohgo Y, Nitsu Y, Kondo H, Kato J. Tsushima N, Sasaki K, et al. Serum trasferrin receptor as a new index of erythropoiesis. Blood 1987;70:1955-8
  16. Brugnara C, Zelmanovic D, Sorette M, Ballas SK, Platt O. Reticulocyte hemoglobin: An integrated parameter for evaluation of erythrocyte activity. Am J Clin Pathol 1997;108:133-42 https://doi.org/10.1093/ajcp/108.2.133
  17. Brugnara C, Chambers LA, Malynn E, Goldberg MA, Kruskall MS. Red cell regeneration induced by subcutaneous recombinant erythropoietin: Iron-deficient erythropoiesis m iron-replete subjects. Blood 1993;81:956-64
  18. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, Mckay P, et al. Detection of functional iron deficiency during erythropoietin treatment: a new approach. BMJ 1992;25:225-6
  19. Burns ER, Goldberg SN, Lawrence C, Wenz B. Clinical utility of serum tests for iron deficiency in hospitalized patients. Am J Clin Pathol 1990;93:240-5 https://doi.org/10.1093/ajcp/93.2.240
  20. Brugnara C, Zurakowski D, DiCanzio J. Boyd T, Platt O, Reticulocyte hemoglobin content to diagnose iron deficiency in children. JAMA 1999;281:2225-30 https://doi.org/10.1001/jama.281.23.2225
  21. Buttarello M, Bulian P, Farina G, Petris MG, Temporin V, Toffolo L. Five fully automated methods for performing immature reticulocyte fraction. Am J Clin Pathol 2002;117: 871-9 https://doi.org/10.1309/VJAA-L52P-FGRM-QGRU
  22. Park KH, Lee YK, Choi TY, Kim WB, Lee DW. Clinical significance of immature reticulocyte fraction determined by automated blood cell analyzer. Korean J Hematol 1999;34: 281-7
  23. Corash L, Rheinschmidt M, Lieu S, Meers P, Brew E. Enumeration of reticulocytes using fluorescence-activated flow cytometry. Pathol Immunopathol Res 1988;7:381-94 https://doi.org/10.1159/000157131
  24. Brugnara C. Reticulocyte cellular indices: a new approach in the diagnosis of anemias and monitoring of erythropoietic function. Crit Rev Clin Lab Sci 2000;37:93-130 https://doi.org/10.1080/10408360091174196
  25. Davis BH. Immature reticulocyte fraction(IRF): By any name, a useful clinical parameter of erythrocpoietic activity. Lab Hematol 1996;2:2-8
  26. Tsuchiya K, Okano H, Teramura M, Iwamoto Y, Nihei H, Ando M, et al. Content of reticulocyte hemoglobin is a reliable tool for determining iron deficiency in dialysis patients. Clin Nephrol 2003;59:115-23 https://doi.org/10.5414/CNP59115
  27. Tatsumi N, Kojima K, Tsuda I, Yamagami S, Itoh Y, Tanaka H. Reticulocyte count used to assess recombinant human erythropoietin sensitivity to hemodialysis patients. Contrib Nephrol 1990;82:41-8
  28. Shin S, Chang JY, Kim JS, Roh EY, Yoon JH. Iron deficiency and hemoglobin content of RBC in infants. Korean J Lab Med 2005;25:14-9
  29. Seo Y, lung HL, Shim JW, Kim DS, Shim JY, Park MS. Clinical significance of immature reticulocyte fraction and reticulocyte cellular indices in pediatric anemia patients. Korean J Pediatr 2005;48:284-91
  30. Fishbane S, Galgano C, Langley RC Jr, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997;52:217-22 https://doi.org/10.1038/ki.1997.323
  31. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem 2002;48:1066-76
  32. Geaghan SM. Hematologic values and appearances in the healthy fetus, neonate, and child. Clin Lab Med 1999;19:1-37